Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L1JW
|
|||
Former ID |
DNAP001604
|
|||
Drug Name |
Hydrastine
|
|||
Synonyms |
HYDRASTINE; 118-08-1; beta-Hydrastine; l-Hydrastine; (-)-Hydrastine; CHEBI:69919; A-Hydrastine; UNII-8890V3217X; EINECS 204-233-0; BRN 0098575; HYDRASTINE (1R, 9S); (1R,9S)-(-)-beta-Hydrastine; 8890V3217X; Phthalide, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-; 6,7-Dimethoxy-3-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinoline-5-yl)-1(3H)-isobenzo furan; 3-((5R)-6-methyl(5,6,7,8-tetrahydro-2H-1,3-dioxoleno[4,5-g]isoquinolin-5-yl))( 3S)-6,7-dimethoxy-3-hydroisobenzofuran-
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Haemostatic astringent [ICD-11: MG27; ICD-10: R58] | Approved | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C21H21NO6
|
|||
Canonical SMILES |
CN1CCC2=CC3=C(C=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OCO3
|
|||
InChI |
1S/C21H21NO6/c1-22-7-6-11-8-15-16(27-10-26-15)9-13(11)18(22)19-12-4-5-14(24-2)20(25-3)17(12)21(23)28-19/h4-5,8-9,18-19H,6-7,10H2,1-3H3/t18-,19+/m1/s1
|
|||
InChIKey |
JZUTXVTYJDCMDU-MOPGFXCFSA-N
|
|||
CAS Number |
CAS 118-08-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
598402, 10262529, 11113244, 11407449, 11466609, 11467729, 11486377, 15078547, 24895532, 33517602, 47500662, 47796176, 47870855, 48244546, 48482897, 49698566, 49854792, 61338237, 77772904, 85787479, 92307688, 113466089, 123101469, 124557344, 134973697, 136182236, 137128408, 141839366, 144075328, 144207884, 160712635, 162224680, 162225628, 163126521, 164788498, 164842212, 175607977, 179236185, 198987200, 226673079, 241201213, 249815145, 252350798, 252402709, 252496851
|
|||
ChEBI ID |
CHEBI:69919
|
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.